About: Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 03 January 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en xineru de 2020 (ast) article scientifique publié en 2020 (fr) наукова стаття, опублікована 3 січня 2020 (uk) scientific article published on 03 January 2020 (en)
publication date	wds:Q99631280-8B1BDBB5-AFF7-47B5-8BD3-194B39C76E34
publication date	2020-01-03 00:00:00Z (xsd:dateTime)
cites work	wds:Q99631280-0CD9079C-AE4A-46F4-A4AB-3B7A6E9761F8 wds:Q99631280-1B1EEB71-835C-4F07-89DB-7D1D07C9585F wds:Q99631280-20D73274-9EDC-472B-9799-8201A7C60F53 wds:Q99631280-239A475C-AE3E-4634-8E79-B57B8CED95B4 wds:Q99631280-246D7CF9-0FA7-44C5-B6C3-3C5F15CC0632 wds:Q99631280-2E060AAB-62B2-4E91-B250-C47ABC206FA4 wds:Q99631280-379AC083-1133-4AFD-A5BE-9D4DEEE6BE34 wds:Q99631280-38AC92DC-F71B-408E-81E2-E4085A557B95 wds:Q99631280-4294E4A3-195B-47DC-99A9-865925C848D9 wds:Q99631280-4DDE92AB-FB85-4475-B4BD-BD82346CF939 wds:Q99631280-5CC79DAB-FF09-4639-9632-77D066B831CF wds:Q99631280-65937552-FC98-48D8-B40D-607F8F89C218 wds:Q99631280-70266F71-B4D4-4997-A2D9-AC68B8046D17 wds:Q99631280-7A0C40C3-6281-488E-B438-4A389770C307 wds:Q99631280-8BCE484F-1031-44F5-8485-7BC0BD1974C1 wds:Q99631280-9E4BB361-94ED-49AE-827F-FFA7A848182F wds:Q99631280-9F005FA0-DDE7-44C8-8B5C-55BD7182C470 wds:Q99631280-C5904126-55FB-4A39-8CB2-50446C1625EE wds:Q99631280-D8E000B7-D7E6-4074-AF1B-6052833175AE wds:Q99631280-D911F81F-24DC-44F5-9680-BBB5C4C94437 wds:Q99631280-E16B737D-31D8-4ABD-B68B-0F569DEC73C7 wds:Q99631280-F3BF0857-99F2-42B4-81F9-EDE1FCA02FFA wds:Q99631280-F3E7C0F5-3DA9-431E-97FC-F49F0B2310E0 wds:Q99631280-FF2496B5-BF8F-4013-B650-FD6936BFC30C
cites work	Metrics for glycaemic control - from HbA1c to continuous glucose monitoring Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes Multinational Home Use of Closed-Loop Control Is Safe and Effective Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes DiAs user interface: a patient-centric interface for mobile artificial pancreas systems Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018 Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial The artificial pancreas in 2017: The year of transition from research to clinical practice. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2019 Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial First Look at Control-IQ: A New-Generation Automated Insulin Delivery System Effectiveness of artificial pancreas in the non-adult population: a systematic review and network meta-analysis Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control
author name string	wds:Q99631280-24B324C0-9EF8-4542-9480-AD86E482C1E9 wds:Q99631280-65D7491C-ADF4-43F4-94A1-7C702FE4878F wds:Q99631280-6B9DA43A-A3DC-4C1D-88B9-410D0495C1B1 wds:Q99631280-813F5AA1-0099-422A-A49E-ECB42165C44E wds:Q99631280-831CEFEE-BF9D-44AE-93F2-000F10261094 wds:Q99631280-93195DDB-4D01-4F82-AF1A-D4934149BEDE wds:Q99631280-B7357C8C-5D56-4897-8C44-7C9AB698DCF8 wds:Q99631280-B7F32546-AD51-41C6-AD67-47A8F7419857 wds:Q99631280-C5E2C42C-7EAB-41CE-B206-2BF6310B533B wds:Q99631280-E4C03E45-FC0A-41B7-AD87-46F8377B04CF
author name string	Boris P Kovatchev Stacey M Anderson Laura Kollar Marc D Breton Sue A Brown Kelly Carr Charlotte Barnett Christian A Wakeman Mary C Oliveri Rachel Gildersleeve
rdfs:label	Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial (en) Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial (nl)
skos:prefLabel	Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial (en) Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial (nl)
name	Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial (en) Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial (nl)
title	wds:Q99631280-C2A3440B-E25D-42B0-B690-0DC54ADC38E2
title	Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial (en)
page(s)	wds:Q99631280-A9345D23-6891-4CF7-85EC-BE8BB2099C95
page(s)	e64-e73
instance of	wds:Q99631280-E3D33498-235C-4ADB-B359-8A4F7CF46EE7
instance of	scholarly article
PubMed ID	wds:Q99631280-22696E47-02EE-46AA-8F79-032CD07D9209
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32864597
PubMed ID	32864597
published in	wds:Q99631280-BA2F13E4-7608-4F10-A3F9-940585147312
published in	Digital Health
issue	wds:Q99631280-BC0885B7-9AF1-4F0D-BD04-EF0D558B74D5
volume	wds:Q99631280-78A337C2-5803-4D3A-A5D7-B44486B02D33
issue	2
volume	2
DOI	wds:Q99631280-8AC4D3D9-238C-4905-AD26-159F2A8FB4B8
DOI	http://dx.doi.org/10.1016/S2589-7500(19)30218-3
DOI	10.1016/S2589-7500(19)30218-3

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software